Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
Virology Journal
|
April 28, 2026
Clinical features and whole-genome snp association study of chronic active Epstein-Barr virus infection in adults
Xuan Mei, Jie Yao, Zhen Guan, et al.
Investigative and Clinical Urology
|
May 2, 2025
Optimizing extraction of microbial DNA from urine: Advancing urinary microbiome research in bladder cancer
Chuang-Ming Zheng, Ho Won Kang, Seongmin Moon, et al.
Journal of Hepatocellular Carcinoma
|
January 2, 2024
Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT
Bang Liu, Jia Liu, Xuan Mei, et al.
Frontiers in Genetics
|
February 12, 2024
Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection
Bang Liu, Ling-Ling Lu, Li Yu, et al.
Journal of Ethnopharmacology
|
February 25, 2018
Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway
Xiong-Zhe Han, Rui Ma, Qi Chen, et al.
Clinical and Translational Medicine
|
May 3, 2023
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling
Jianpeng Yu, Tianyu Shen, Yang Li, et al.
The Journal of Antibiotics
|
May 30, 2024
Cytotoxic glutarimide-containing polyketides isolated from Streptomyces sp. JCM 4793
Lin-Fang Tang, Wu-Lai Jihuo, Pei-Dong Shi, et al.
Prostate International
|
February 14, 2022
Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer
Young Joon Byun, Ho Won Kang, Xuan-Mei Piao, et al.
Oncology Letters
|
November 8, 2024
Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone
Won Tae Kim, Kyeong Kim, Ho Won Kang, et al.
Bioactive Materials
|
August 20, 2024
An infusible biologically active adhesive for chemotherapy-related heart failure in elderly rats
Jialu Yao, Junlang Li, Dashuai Zhu, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
Virology Journal
|
April 28, 2026
Clinical features and whole-genome snp association study of chronic active Epstein-Barr virus infection in adults
Xuan Mei, Jie Yao, Zhen Guan, et al.
Investigative and Clinical Urology
|
May 2, 2025
Optimizing extraction of microbial DNA from urine: Advancing urinary microbiome research in bladder cancer
Chuang-Ming Zheng, Ho Won Kang, Seongmin Moon, et al.
Journal of Hepatocellular Carcinoma
|
January 2, 2024
Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT
Bang Liu, Jia Liu, Xuan Mei, et al.
Frontiers in Genetics
|
February 12, 2024
Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection
Bang Liu, Ling-Ling Lu, Li Yu, et al.
Journal of Ethnopharmacology
|
February 25, 2018
Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway
Xiong-Zhe Han, Rui Ma, Qi Chen, et al.
Clinical and Translational Medicine
|
May 3, 2023
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling
Jianpeng Yu, Tianyu Shen, Yang Li, et al.
The Journal of Antibiotics
|
May 30, 2024
Cytotoxic glutarimide-containing polyketides isolated from Streptomyces sp. JCM 4793
Lin-Fang Tang, Wu-Lai Jihuo, Pei-Dong Shi, et al.
Prostate International
|
February 14, 2022
Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer
Young Joon Byun, Ho Won Kang, Xuan-Mei Piao, et al.
Oncology Letters
|
November 8, 2024
Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone
Won Tae Kim, Kyeong Kim, Ho Won Kang, et al.
Bioactive Materials
|
August 20, 2024
An infusible biologically active adhesive for chemotherapy-related heart failure in elderly rats
Jialu Yao, Junlang Li, Dashuai Zhu, et al.
Page
of 11